BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mondal P, Meeran SM. microRNAs in cancer chemoresistance: The sword and the shield. Noncoding RNA Res 2021;6:200-10. [PMID: 34977437 DOI: 10.1016/j.ncrna.2021.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li R, Chen Z, Zhou Y, Maimaitirexiati G, Yan Q, Li Y, Maimaitiyimin A, Zhou C, Ren J, Liu C, Mainike A, Zhou P, Ding L. LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion. Front Oncol 2022;12:967000. [DOI: 10.3389/fonc.2022.967000] [Reference Citation Analysis]
2 Mahinfar P, Mansoori B, Rostamzadeh D, Baradaran B, Cho WC, Mansoori B. The Role of microRNAs in Multidrug Resistance of Glioblastoma. Cancers 2022;14:3217. [DOI: 10.3390/cancers14133217] [Reference Citation Analysis]
3 Khan MI, Alsayed RKME, Choudhry H, Ahmad A. Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery. Int J Mol Sci 2022;23:6222. [PMID: 35682901 DOI: 10.3390/ijms23116222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Gaál Z. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation. Int J Mol Sci 2022;23:5838. [PMID: 35628648 DOI: 10.3390/ijms23105838] [Reference Citation Analysis]